Madrigal Pharmaceuticals
MDGL
#1762
Rank
HK$93.32 B
Marketcap
HK$4,068
Share price
-0.89%
Change (1 day)
65.42%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2025 (TTM): -HK$2.08 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.95 Billion. , an increase over its 2024 earnings that were of -HK$3.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 -HK$2.09 Billion-41.05%
2024 -HK$3.54 Billion25.02%
2023 -HK$2.83 Billion23.86%
2022 -HK$2.29 Billion20.24%
2021 -HK$1.9 Billion17.25%
2020 -HK$1.62 Billion117.61%
2019 -HK$0.75 Billion189.45%
2018 -HK$0.26 Billion3.85%
2017 -HK$0.25 Billion25.71%
2016 -HK$0.2 Billion-50.81%
2015 -HK$0.41 Billion-39.14%
2014 -HK$0.66 Billion-4.12%
2013 -HK$0.69 Billion
2011 -HK$0.36 Billion23.13%
2010 -HK$0.29 Billion-145.81%
2009 HK$0.63 B-185.95%
2008 -HK$0.74 Billion41.52%
2007 -HK$0.52 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.25 Billion-40.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion-93.17%๐Ÿ‡บ๐Ÿ‡ธ USA